SCRSF - ScreenPro files application with US patent agency for rapid breast cancer screening test
ScreenPro Security (OTCPK:SCRSF) said its unit Add Biomedical submitted an application to the U.S. Patent and Trademark Office (USPTO) for a Cancer Antigen (CA) 15-3 rapid testing kit for breast cancer screening. The company said the CA 15-3 screening test can detect early-stage breast cancer before it develops and therefore it can significantly reduce the lethal rate and risk to patients.
For further details see:
ScreenPro files application with US patent agency for rapid breast cancer screening test